A detailed history of Israel Englander (Millennium Management LLC) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 455,564 shares of MIRM stock, worth $19.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
455,564
Previous 265,443 71.62%
Holding current value
$19.9 Million
Previous $9.08 Million 95.77%
% of portfolio
0.01%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.68 - $44.74 $6.4 Million - $8.51 Million
190,121 Added 71.62%
455,564 $17.8 Million
Q2 2024

Aug 14, 2024

SELL
$23.57 - $34.85 $6.46 Million - $9.56 Million
-274,223 Reduced 50.81%
265,443 $9.08 Million
Q1 2024

May 15, 2024

BUY
$24.92 - $30.02 $7.86 Million - $9.47 Million
315,290 Added 140.52%
539,666 $13.6 Million
Q4 2023

Feb 14, 2024

BUY
$27.14 - $34.93 $6.09 Million - $7.84 Million
224,376 New
224,376 $6.62 Million
Q1 2023

May 15, 2023

BUY
$19.19 - $24.1 $294,815 - $370,248
15,363 New
15,363 $369,000
Q2 2022

Aug 15, 2022

SELL
$18.42 - $27.5 $425,778 - $635,662
-23,115 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$15.5 - $23.93 $383,563 - $592,171
-24,746 Reduced 51.7%
23,115 $509,000
Q4 2021

Feb 14, 2022

SELL
$13.05 - $19.35 $1.11 Million - $1.64 Million
-84,725 Reduced 63.9%
47,861 $763,000
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $1.22 Million - $1.77 Million
87,615 Added 194.83%
132,586 $2.64 Million
Q2 2021

Aug 16, 2021

SELL
$15.84 - $20.6 $599,876 - $780,142
-37,871 Reduced 45.71%
44,971 $778,000
Q1 2021

May 17, 2021

SELL
$16.29 - $21.92 $3.16 Million - $4.25 Million
-194,033 Reduced 70.08%
82,842 $1.64 Million
Q4 2020

Feb 16, 2021

BUY
$15.75 - $25.45 $1.04 Million - $1.67 Million
65,796 Added 31.17%
276,875 $4.83 Million
Q3 2020

Nov 16, 2020

BUY
$18.4 - $26.59 $3.68 Million - $5.32 Million
200,241 Added 1847.58%
211,079 $4.07 Million
Q2 2020

Aug 14, 2020

SELL
$11.51 - $20.97 $972,123 - $1.77 Million
-84,459 Reduced 88.63%
10,838 $211,000
Q1 2020

May 14, 2020

BUY
$9.38 - $23.79 $684,983 - $1.74 Million
73,026 Added 327.9%
95,297 $1.33 Million
Q4 2019

Feb 14, 2020

SELL
$6.84 - $25.9 $705,566 - $2.67 Million
-103,153 Reduced 82.24%
22,271 $546,000
Q3 2019

Nov 14, 2019

BUY
$9.16 - $14.77 $1.15 Million - $1.85 Million
125,424 New
125,424 $1.26 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.61B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.